Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Would be nice if he could announce funding through an OZ and moving to a capable facility.
Funding for magnetec is the only market mover I know of.
Who knows how NP acts in those negotiations. If he walks in arrogant and pompous people will just walk.
I’ve seen it before...
Covid will wind down... demand will fall considerably with therapeutics and vaccine. Great flip but this seems like they missed the opportunity. Got a few more months to milk it though...
Seems like a long shot at this point. Ever wonder why lesser unproven MABS get gov funding and cydy doesnt?
Long way from 390.... plenty of people... interesting they are having trouble filling
100million market cap? Yeah, I’ll sell that... doesn’t match up with the fins.
Show me a contract for purchases of 78,000 RXAir3000 units and I’ll ride it to $0.50
Curious... is there anything legal that prevents them from buying PASO stock right now?
Seems like a good price. Or are they they aware of what pubco is being merged?
10k due Monday right? Are they going to bother filing?
No it can’t.... but if they LICENSE it and make money passively on all indications then I guarantee all will be well.
NP is nuts to try and monopolize leronlimab all to himself. He’ll bury it if he tries.
The old “I’m taking my ball and going home”.... well guess what... you won’t win a game.
This is a Shaq dunk.... easy. But still can be duffed.
It’s not a reflection of the drug... it’s a vote on the CEO’s inability to act like one.
Too much hype to action ratio.
Anyway we can stop these cheesy pump proactive videos? It’s not in good biopharm taste. Reeks of otc
We won’t know what they’ve sold until the next Q.
Have they shipped any at all? Or is this all future hype?
Sell the news...
I used to work for a guy just like NP. Same situation, huge bully and very narcissistic. However if you dig deep it comes from insecurity.
I ran the firm for 5 years... he constantly unintentionally sabotaged progress through his need to be out in front and in control. I told him to shut up and take the huge checks... he couldn’t do it.
Same nightmare... BOD should take a vote and send him to a white room.
A guy like NP is a coin... extreme pros and cons. Big volatile rollercoaster. Institutional investors will want him gone...
BOD has to sack up and control this situation.
That’s a good way to let the short positions scare off new investors.
He has quality advisors but he puts himself out in front of them. NP... stop talking.
No a sell is betting that Cydy misses the Covid opportunity.
No one will buy this if they don’t get a Covid Indication.
He’s a pumper. The other Drs are very balanced and in message. You can tell NP is overselling.
Start nailing the BOD demanding that NP stop the pump videos and let the Drs run the calls.
He needs a GP BOD seat and to help select next CEO.
... or stop talking and let Scott Kelly do the promos and CCs
Is this the start of a national PR campaign? Seems like a launch of VYStar to me...
Sounds accurate
Well that would be nice...
If you’re bugging the shit out of JG raise your hand.
Likely just more insider info leaking, see Twitter update just now
.70 target... just for RXAir. Don’t know valuation of Rubber or FEC yet.
“Feels”... can’t bet on that.
Patterson talks people buy, NP talks people sell.
I’ll hedge and buy triple leveraged oil, airlines, etc.
At some point we’ll be clear of Covid, CYDY May or may not be part of the solution.
Ask is rather high... MMs not interested in making a market here as the liquidity has dried up.
Looks like someone is gobbling up the cheap shares.
Chas getting close to the OZ move?
Standard 4 is obviously met.
You’d have to grab the latest protocol from the hospitals. Math+ is a good one. Also, they know more about ventilation and intubation.
Little is known about leronlimab and even then you could get a placebo. If I know nothing about LL and I might not even get it then I’d opt out and take the Math+ protocol.
Yeah, pretty dumb there. Not effective.
... but they do meet the requirements.
Sweet... drop it like a rock.
Maybe they aren’t so desperate to join in for an unknown experimental drug or placebo when the SOC is better than before?
People do want to live typically.
Sums it up pretty well
Sounds like the FDA wants unquestionable bulletproof data and will leverage human life to get it. Sounds like they were more concerned with the drug arm causing harm which we know already had safety efficacy.
Patients get lost in the protocols.... maybe not “enough” died in the placebo arm to be statistically significant? The baseline non-drug SOC for Covid has improved so death rates have gone down. Had they ran the S2C in New York in March then it would have likely been halted. With that being said the primary endpoint is not as significant as we speculated. Secondary endpoints will be more critical and that’s where LL shines in terms of immunomodulation of CD4/CD8.
Sucks to be in that placebo group... they had a chance to get LL. DSMC denied.
There it is, no S2C halt, trial to continue...
That won’t fly. All trials would be subject to same re-scrutiny then and the ethics of all CYDY clinical sites would be in question. That’s a huge ethical accusation he’d be making. The institutions running these trials are not backwoods facilities... they are prestigious.
Their only option would be to deliberate internally and drag out the EA until a vaccine is in hand or another MAB shows efficacy.
Neither is likely... LL will be one choice in a basket of MABs.
Bullish move
VYST, Heavy lift let’s get to .35 EOM... let’s go!